- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint alleged Serono’s international conference invitations were a non-transparent inducement to prescribe. Panel found no evidence of inappropriate hospitality or delegate selection;…
PCT prescribing advisor challenged a Bonviva leavepiece using 62% vertebral fracture reduction data from a 2.5mg daily study in a 150mg monthly…
PMCPA raised a Paragraph 17 case after seeing Servier training slides on accessing hospital staff. The Panel said the slides encouraged inappropriate…
A detachable MIMS page tag showing only the brand name Acomplia was ruled to be an advertisement, not a promotional aid, so…
PMCPA case AUTH/3001/12/17 (Director v Sunovion) concerning clinical trial disclosure for Latuda. The case was found to be out of scope of…
PMCPA case AUTH/2998/12/17 (Director v Lilly) concerning clinical trial disclosure for Cyramza. The matter was found to be outwith the scope of…
A public complaint about clinical trial disclosure for Lyxumia was ruled outwith the scope of the ABPI Code (2012). No case report…
A member of the public complained to the PMCPA about clinical trial disclosure for Cimzia. The matter was deemed outwith the scope…
Former employee challenged MSD internal memos about an audit protocol and a field-force briefing on Schering-Plough PDMs. Panel found the communications were…
A GP alleged an Ipsen rep implied Decapeptyl could be used beyond its licence by describing use when cancer had spread beyond…
A GP complained after a care home duty manager asked for BuTrans. PMCPA found no public advertising breach, but ruled the leavepiece…
A GP complained that a Cipralex cost bar chart implied generic competitor prices but actually used branded prices. The Panel said the…
A PCT complained a sponsored ‘Primary Care Report’ looked like disguised promotion for Clenil Modulite and misquoted DoH policy. The PMCPA Panel…
Anonymous GP alleged free-loan I-neb nebulisers with Promixin were an inducement and that reps made unproven dose-equivalence claims. Panel found the package…
Allergan press-release content placed in trade journals implied Bocouture/Xeomin was less potent than Vistabel/Botox. PMCPA ruled breach of undertaking (Clause 25) and…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.